Information About Legal Rights Pertaining to BioMet Hip Replacements
Patients with BioMet M2a Magnum hip replacement devices have reported experiencing severe hip pain, swelling and difficulty walking. These symptoms may be caused by problems with the BioMet M2a Magnum hip device such as metallosis, a type of metal poisoning, hip implant loosening, fretting and corrosion, dislocation and fractures at the site of the implant.
The Australian National Joint Registry conducted a study of BioMet hip replacements in 2011 and found that patients implanted with BioMet M2A Magnum hips had a revision surgery rate of 7.2 percent. Despite the fact that this revision rate is much higher than revision rates of other hip replacement devices, the U.S. Food and Drug Administration (FDA) has not issued a BioMet recall.
The BioMet M2a Magnum hip replacements were approved under the Food and Drug Administration’s 510(k) program. This program allows manufacturers to bypass clinical trials if their device is substantially similar to a device already approved by the FDA.
If you were implanted with a defective BioMet hip replacement system and experienced fretting or corrosion, metal poisoning, fractures or other complications that required hip revision surgery, you may be eligible to file a lawsuit. Contact the lawyers at Hissey Kientz, LLP to learn more about your legal rights by calling toll free at 1-866-275-4454, or by filling out a free case evaluation form on the right of this page.